Patent 7442532 was granted and assigned to Bristol-Myers Squibb on October, 2008 by the United States Patent and Trademark Office.
The present invention provides essential fungal polynucleotides and their encoded polypeptides, homologues thereof and their uses. Additionally, the invention provides methods for the identification of essential polynucleotides and fungal strains which may be used for drug screening.